Statement on Proposed Federal Rule Change that Would Expose MAT Patients to Criminal Investigations

New York, NY – Below is a statement from Lindsay LaSalle, Director of Public Health Law and Policy, Drug Policy Alliance, in response to a new rule proposed by the federal government—more specifically the Substance Abuse and Mental Health Services Administration (SAMHSA)—that would scrap patient confidentiality requirements and expose medication-assisted treatment (MAT) patients to criminal […]

Drug Policy Alliance Proposes Bold Solutions on International Overdose Awareness Day

New York, NY – In recognition of International Overdose Awareness Day (August 31), the Drug Policy Alliance (DPA) is urging policymakers to adopt Bold Solutions to the Overdose Crisis, including innovative harm reduction, drug education, evidence-based treatment and policy solutions in order to make a concerted dent in the overdose crisis, which claimed nearly 70,000 […]

DPA Analysis of 2018 National Survey of Drug Use and Health (NSDUH)

New York, NY – Below is analysis from Sheila Vakharia, PhD, Deputy Director of the Drug Policy Alliance’s Department of Research and Academic Engagement, in response to the 2018 National Survey of Drug Use and Health released today by SAMHSA. Among the findings: Youth rates of marijuana use remain mostly unchanged in recent years, while […]

Statement on Bernie Sanders Adding Safe Consumption Sites to His 2020 Platform

New York, NY – Below is a statement from Maria McFarland Sánchez-Moreno, Executive Director of Drug Policy Action, in response to 2020 presidential contender Sen. Bernie Sanders adding supervised consumption sites to his criminal justice platform. “Senator Bernie Sanders has rightly recognized the life-saving value of supervised consumption sites as a way to curb the […]

Statement on Proposed Trump Administration Rule to Require Drug Testing in Order to Receive Unemployment Benefits

August 15, 2019 – New York, NY – Below is a statement from Maria McFarland Sánchez-Moreno, Executive Director of the Drug Policy Alliance, in response to an attempt by the Trump Administration to require drug testing in order to receive unemployment benefits: “This latest push to require people seeking unemployment benefits to undergo drug testing […]

Statement on New CDC Report Showing Slight Increase in Naloxone Dispensing – But Still Lags Compared to Overall Opioid Prescribing

New York, NY – Below is a statement from Sheila Vakharia, PhD, Policy Manager and Researcher with the Drug Policy Alliance, in response to a new CDC report showing that, in 2018, while naloxone dispensing by pharmacies did increase slightly from 2017, still only one naloxone prescription was dispensed for every 69 high-dose opioid prescriptions. “It is […]

Statement on New York Governor Andrew Cuomo Signing Marijuana Decriminalization Bill

NEW YORK, NY – Below is a statement from Melissa Moore, Deputy State Director for Drug Policy Alliance New York, on the marijuana decriminalization bill signed this morning by New York Governor Andrew Cuomo: “The inability of the state legislature and Governor Cuomo to pass comprehensive marijuana legalization this legislative session means that Black and Latinx […]

Statement on NYC Council’s Passage of Key Marijuana Legislation that Keeps Families Together & Protects Pregnant Mothers’ Rights

Drug Policy Alliance Statement on NYC Council’s Passage of Vital Legislation that Safeguards Families from Separation Based on Marijuana Use or Possession Alone and Protects Pregnant Mothers’ Rights against Nonconsensual Drug Testing New York, NY – Following New York City Council’s passage of Resolution 740, which keeps the Administration for Children’s Services from being able […]

1 20 21 22
Right Menu Icon